Separate Research

 
Fund Quotes for Separate Research top ^
  • Category: Multisector Bond
  • Morningstar Rating: 5 Stars
Sign-up for smarx investment picks

 
News Articles for Separate Research top ^
TEL AVIV, Israel , November 25, 2014 /PRNewswire/ -- ILCO announces shareholders' meeting to be held on December 31st to approve the proposed separation of its holdings, and publishes full transaction report detailing the process and proposed new structure ILCO's new strategic focus following the separation will be on its remaining public holdings, Israel Chemicals (NYSE:ICL, TASE:ICL) and Bazan (TASE:ORL), and it will refrain from investing in new companies.
Sign-up for Israel Corporation Moves Forward With the Proposed Strategic Separation of its Holdings investment picks
2014/10/28
By Quentin Fottrell, MarketWatch Facebook's "like" button reveals a lot about cultural activities of Democrats and Republicans.
Sign-up for Facebook's 'like' button separates Democrats from Republicans investment picks
2014/11/25
Fun interactive demo shows source of most holiday calories CHELMSFORD, Mass.
Sign-up for Datawatch Helps Separate Thanksgiving Fat From Lean with Data Visualization investment picks
- Bob Skaggs, Joe Hamrock expected to lead experienced teams at both companies - Plans for CPG Board of Directors leadership announced MERRILLVILLE, Ind.
Sign-up for Post-separation leaders named for Columbia Pipeline Group, NiSource investment picks
2014/12/5
- Amended $1.5 billion facility at NiSource - New $1.5 billion facility at Columbia Pipeline Group - New $500 million facility at Columbia Pipeline Partners MERRILLVILLE, Ind.
Sign-up for NiSource closes on revolving credit facilities to support post-separation operations investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of the first human study evaluating the reversal of the anticoagulant effect of Eliquis (apixaban) by 4-factor prothrombin complex concentrates (PCCs) in healthy subjects.
Sign-up for Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects investment picks
BEACHWOOD, Ohio , Jan.
Sign-up for DDR and CEO Daniel Hurwitz Finalize Separation investment picks
- A six-week dual NS5A – Nuc regimen of ACH-3102 and sofosbuvir was safe and well-tolerated with 100 percent SVR4 for treatment-naïve genotype 1 HCV ("Proxy Study") NEW HAVEN, Conn., Dec.
Sign-up for Achillion Shows Potential for "Best-in-Disease" HCV Regimen - 100% SVR4 Following a Dual 6-Week ACH-3102-Based Regimen and Separately a 4.8 Log10 Reduction With ACH-3422 investment picks
Clean Harbors Inc. (CLH) said Tuesday it is carving out its oil and gas field services business into a standalone public entity, following a strategic review.
Sign-up for Clean Harbors to carve out oil and gas field services business into separate entity investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Separate Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Separate Companies  |  Next: September Quarter